13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE 13D/A Filed 2026-04-02 Event 2026-03-31 SEC 0000921895-26-000894 →

BIOTECHNOLOGY VALUE FUND L P MoonLake Immunotherapeutics MLTX

Stake: 22.30% Shares: 8,302,735 CUSIP: 61559X104 Class: Class A ordinary share, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
1 filings by this filer
0 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 7.78
7,757,169 shares short · +6.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $10.18M
Point72 Asset Mgmt

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →